Savolitinib and durvalumab for metastatic papillary kidney cancer
In a phase 2 clinical trial, patients with metastatic papillary [...]
In a phase 2 clinical trial, patients with metastatic papillary [...]
In a recent study published in the Journal of Clinical [...]
In this study, real world data is used to compare [...]
Papillary renal cell carcinoma (pRCC) is the second most common [...]
At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]
A biomarker is a biological molecule found in blood, other [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
A gene called MET codes for a protein called MET [...]
A recent study published in JAMA Network Open looked at [...]
In this phase 2 clinical trial, a combination of everolimus [...]